Literature DB >> 26235416

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].

Elisabeth Luporsi1, Jean-Pierre Bellocq2, Jérôme Barrière3, Julia Bonastre4, Jérôme Chetritt5, Anne-Gaëlle Le Corroller6, Patricia de Cremoux7, Frédéric Fina8, Anne-Sophie Gauchez9, Pierre-Jean Lamy10, Pierre-Marie Martin8, Chafika Mazouni4, Jean-Philippe Peyrat11, Gilles Romieu10, Laetitia Verdoni12, Valérie Mazeau-Woynar12, Diana Kassab-Chahmi13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26235416     DOI： 10.1016/j.bulcan.2015.05.003

Source DB:  PubMed          Journal:  Bull Cancer        ISSN： 0007-4551            Impact factor:   1.276


× No keyword cloud information.
  6 in total

1.  Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.

Authors:  Baoqing Tian; Xiaojia Chen; Huihua Zhang; Xiaoyan Li; Jiakang Wang; Wei Han; Li-Yi Zhang; Li Fu; Yan Li; Changjun Nie; Ying Zhao; Xuan Tan; Hailong Wang; Xin-Yuan Guan; An Hong
Journal:  Oncotarget       Date:  2017-06-27

2.  Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers.

Authors:  Elise Deluche; Laurence Venat-Bouvet; Sophie Leobon; Veronique Fermeaux; Joelle Mollard; Nadira Saidi; Isabelle Jammet; Yves Aubard; Nicole Tubiana-Mathieu
Journal:  BMC Cancer       Date:  2017-09-27       Impact factor: 4.430

Review 3.  Progress in the clinical detection of heterogeneity in breast cancer.

Authors:  Jun-Long Song; Chuang Chen; Jing-Ping Yuan; Sheng-Rong Sun
Journal:  Cancer Med       Date:  2016-10-24       Impact factor: 4.452

4.  Circulating uPA as a potential prognostic biomarker for resectable esophageal squamous cell carcinoma.

Authors:  Xiao He; Xiaoling Xu; Guanxia Zhu; Hong Ye
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 5.  Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

Authors:  Marie Alexandre; Aurélie Maran-Gonzalez; Marie Viala; Nelly Firmin; Véronique D'Hondt; Marian Gutowski; Céline Bourgier; William Jacot; Séverine Guiu
Journal:  Cancer Manag Res       Date:  2019-12-11       Impact factor: 3.989

Review 6.  Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine.

Authors:  Adel Gouri; Aoulia Dekaken; Khalid El Bairi; Arifa Aissaoui; Nihad Laabed; Mohamed Chefrour; Joseph Ciccolini; Gérard Milano; Sadek Benharkat
Journal:  Biomark Insights       Date:  2016-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.